Telehealth’s pandemic-era explosion fundamentally changed how healthcare is delivered, but the sector’s post-pandemic evolution has been more nuanced than simple continued growth. The initial surge in virtual visits has normalized, and the telehealth industry is now in a maturation phase — separating companies with sustainable business models from those that rode temporary demand. For growth investors, this maturation creates both challenge and opportunity: valuations have reset to more reasonable levels, and the companies emerging as winners are building durable businesses that integrate virtual care into the broader healthcare system rather than treating it as a standalone novelty.
The telehealth opportunity remains substantial despite the post-pandemic normalization. Virtual care addresses fundamental healthcare challenges — provider shortages, geographic access barriers, rising costs, and chronic disease management — that aren’t going away. The question for investors isn’t whether telehealth will be important, but which companies and business models will capture the most value as virtual care evolves from emergency stopgap to permanent healthcare infrastructure.
The Evolving Telehealth Landscape
Pure-Play Virtual Care Platforms
Pure-play telehealth companies — those whose primary business is delivering healthcare virtually — face both the greatest opportunity and the greatest challenge. They offer comprehensive virtual care spanning primary care, mental health, chronic disease management, and specialty consultations. However, they compete with traditional health systems that have built their own telehealth capabilities and with tech companies entering the healthcare space.
The most successful pure-play telehealth companies are those that have expanded beyond simple video visits into integrated chronic care management, offering ongoing virtual relationships with care teams, remote patient monitoring, and prescription management. This shift from transactional visits to continuous care relationships increases customer lifetime value and reduces churn — critical for sustainable growth.
Physician Network Platforms
Companies that build digital platforms connecting physicians with pharmaceutical companies, health systems, and other healthcare stakeholders represent a differentiated approach to telehealth. Rather than delivering care directly, these platforms generate revenue from pharmaceutical marketing, continuing medical education, hiring services, and telehealth infrastructure. This B2B model can be more profitable and less sensitive to consumer demand fluctuations than direct-to-consumer telehealth.
The leading physician network platform has demonstrated resilient growth by diversifying revenue streams beyond telemedicine, with pharmaceutical subscriptions and health system engagement driving steady expansion even as pure telehealth companies face headwinds.
Hybrid Care Models
The most promising telehealth model may be hybrid care — combining virtual and in-person interactions to deliver healthcare more efficiently and effectively than either approach alone. Companies that integrate telehealth with physical clinics, digital health tools, home health services, and remote monitoring devices can offer comprehensive care that improves outcomes while reducing costs.
Large healthcare and pharmacy companies are building hybrid models that leverage their existing physical infrastructure (retail clinics, pharmacies, hospitals) with telehealth capabilities. These integrated approaches benefit from existing customer relationships, established insurance contracts, and the convenience of offering patients seamless transitions between virtual and in-person care.
Mental Health Telehealth
Mental and behavioral health has emerged as one of telehealth’s strongest use cases. Virtual therapy and psychiatry address a critical shortage of mental health providers while offering patients the convenience and reduced stigma of accessing care from home. Mental health telehealth companies have demonstrated strong growth and retention, as patients often maintain ongoing therapeutic relationships that generate recurring revenue over extended periods.
Key Metrics for Telehealth Evaluation
Revenue Model and Quality
Evaluate whether revenue comes from per-visit fees (transactional), subscriptions (recurring), enterprise contracts (B2B), or advertising and sponsorship (platform). Subscription and enterprise models provide greater predictability and typically command higher valuations than transactional visit-based revenue. Track the trajectory of revenue mix — companies shifting toward higher-quality, more recurring revenue streams are improving their long-term positioning.
Member and Visit Metrics
Track active members (or patients), visit volume, and revenue per member/visit over time. The most important trend is revenue per member — growing per-member revenue indicates successful cross-selling of services and deepening patient engagement. Declining per-member revenue may signal commoditization or competition.
Clinical Outcomes and Quality Metrics
Telehealth companies increasingly need to demonstrate that virtual care delivers outcomes comparable to or better than in-person care. Companies that can point to clinical data showing improved outcomes, higher patient satisfaction, and lower total cost of care have stronger value propositions for both patients and payers. Quality metrics are becoming essential for securing payer contracts and regulatory support.
Unit Economics
Evaluate the unit economics of patient acquisition and retention. What does it cost to acquire a new patient? What is the lifetime value of a patient relationship? Are unit economics improving or deteriorating as the company scales? Companies with strong unit economics can grow profitably; those with poor economics may never reach sustainable profitability regardless of revenue growth.
Regulatory and Reimbursement Dynamics
The telehealth regulatory landscape remains in flux, creating both opportunity and risk. During the pandemic, temporary regulatory waivers dramatically expanded telehealth access — allowing patients to receive virtual care from home, expanding the types of services covered, and enabling across state lines practice. As these temporary provisions expire or are replaced by permanent rules, the regulatory environment will significantly impact telehealth company economics.
Key regulatory factors to monitor include Medicare telehealth reimbursement policies (which set the benchmark for private payer reimbursement), state-level telehealth practice laws (which govern where and how telehealth can be delivered), and prescribing regulations (particularly for controlled substances and specialty medications). Companies operating in regulatory-favorable niches or with diversified revenue less dependent on specific reimbursement rules are better positioned to navigate regulatory uncertainty.
Investment Themes for 2026
AI-Enhanced Virtual Care
The integration of artificial intelligence into telehealth platforms is creating new capabilities and efficiencies. AI can assist with triage (directing patients to appropriate care levels), documentation (reducing administrative burden on providers), clinical decision support (helping providers make more informed decisions), and patient monitoring (analyzing data from wearable devices to detect deterioration). Companies that effectively integrate AI into their care delivery can serve more patients with fewer providers, dramatically improving unit economics.
Chronic Disease Management
Managing chronic conditions — diabetes, hypertension, heart disease, obesity — through continuous virtual monitoring and coaching represents the highest-value application of telehealth. Chronic disease accounts for 90% of US healthcare spending, and virtual management models that improve adherence, reduce emergency visits, and slow disease progression create enormous value for patients, providers, and payers. Companies building comprehensive chronic disease management platforms with demonstrated outcomes data are well-positioned for sustained growth.
Employer-Sponsored Virtual Care
Employers are increasingly offering telehealth benefits as part of their healthcare packages, seeking to improve employee access to care while managing healthcare costs. B2B telehealth companies that serve employers benefit from multi-year contracts, predictable revenue, and the leverage of employer relationships to reach large patient populations efficiently.
Risk Factors
Reimbursement Risk
Changes in telehealth reimbursement — particularly the expiration of pandemic-era Medicare provisions — could significantly impact revenue for companies dependent on fee-for-service virtual visits. Companies with diversified revenue models less dependent on specific reimbursement policies are more resilient.
Competition
The telehealth market is intensely competitive, with traditional health systems, tech giants, pharmacy chains, and startups all vying for patients. Companies that can differentiate through clinical quality, patient experience, integration with existing healthcare infrastructure, or specialized capabilities (mental health, chronic disease, specific populations) are better positioned than those competing primarily on price or convenience.
Profitability Challenges
Many telehealth companies remain unprofitable, having invested heavily in growth during the pandemic boom. As growth normalizes, the path to profitability depends on achieving efficient unit economics, reducing customer acquisition costs, and expanding revenue per patient. Companies that cannot demonstrate improving profitability trajectories face the risk of running out of capital before reaching sustainability.
Building a Telehealth Portfolio
A balanced telehealth portfolio should include diversified healthcare companies with substantial telehealth operations (40-50% — these provide telehealth exposure with the stability of broader healthcare businesses), physician platform and B2B telehealth companies (25-35% — these typically have more profitable business models less dependent on consumer demand), and select pure-play telehealth companies with demonstrated clinical outcomes, improving unit economics, and clear paths to profitability (15-25%).
Telehealth has moved from a pandemic-era experiment to a permanent component of healthcare delivery. The companies that will create the most value are those building integrated, sustainable care models that demonstrably improve health outcomes while reducing costs. For growth investors who look beyond the hype and focus on business model quality, clinical differentiation, and financial sustainability, telehealth offers meaningful opportunities to participate in the ongoing transformation of healthcare delivery.